CAS 892243-35-5

IPR-803

CAS: 892243-35-5

IPR-803

Purezza: ≥95%

Peso molecolare: 453.49g/mol

Ref: 54-BUP01658

IPR-803

CAS: 892243-35-5

IPR-803 is a potent anticancer drug that belongs to the class of kinase inhibitors. It has been shown to induce apoptosis in human and Chinese hamster cancer cells by inhibiting the activity of proteins involved in cell growth and division. IPR-803 is derived from ranitidine, a medicinal compound used to treat ulcers and acid reflux. It has been found to be effective against various types of tumors and has shown promising results in clinical trials. This drug is excreted through urine and has low toxicity levels, making it a promising candidate for future cancer treatments.

Formula: C₂₇H₂₃N₃O₄

Purezza: Min. 95%

Peso molecolare: 453.5 g/mol

Ref: 3D-SKB24335

IPR-803

CAS: 892243-35-5

IPR-803 is an effective inhibitor of the uPAR·uPA protein-protein interaction (PPI) with anti-tumor activity.

Formula: C₂₇H₂₃N₃O₄

Purezza: 95%

Colore e forma: Solid

Peso molecolare: 453.49

Ref: TM-T11666